Sun Life and Medzown team up to expand access to clinical trials for cancer and other complex diseases
Sun Life U.S. partnered with precision medicine firm Medzown to expand access to clinical trials for employees of self-insured employers. The collaboration integrates Medzown's AI-powered model into Sun Life's stop-loss offering to identify patients with cancer or other complex conditions who qualify for advanced therapies.
Key figures
- Us employees
- 8300
- Us members served
- 48000000
- Avg ortho msk cost
- $120,000
- Assets under management
- C$1.58 trillion
- Avg cancer cost per individual
- $252,000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.